1-2 of 2
Marcos Roberto Pedron Oltramari
Close
Sort by
Journal Articles

The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

Fernanda Borges da Silva, Lorena Lobo de Figueiredo-Pontes, Maria Isabel Ayrosa Madeira, Luisa Corrêa de Araujo Koury, Ana Silvia Gouvêa de Lima, Priscila Santos Scheucher, Juan Luiz Coelho-Silva, Katia Borgia Barbosa Pagnano, Ronald Pallota, Maria de Lourdes Chauffaille, Marcos Roberto Pedron Oltramari, Rosane Isabel Bittencourt, Marcia Higashi, Rodrigo Miguel Bendlin, Elvira Deolinda Rodrigues Pereira Velloso, Bob Lowenberg, Arnold Ganser, Nancy Berliner, Peter Valk, Eduardo Magalhães Rego, Fabiola Traina
Journal: Blood Advances
Blood Adv (2017) 1 (Suppl): 86–89.
https://doi.org/10.1182/bloodadvances.2017GS102419
Published: 2017
Journal Articles

Feasibility of minimal residual disease studies by multiparametric flow cytometry for acute myeloid leukemia in a developing country

Lorena Lobo de Figueiredo-Pontes, Maria Isabel Ayrosa Madeira, Luisa Koury Corrêa de Araujo, Priscila Santos Scheucher, Fabíola Traina, Ana Silvia Gouvêa de Lima, Katia Pagnano, Ronald Pallota, Rosane Bittencourt, Maria de Lourdes Chauffaille, Marcos Roberto Pedron Oltramari, Marcia Higashi, Rodrigo Miguel Bendlin, Elaine Coustan-Smith, Dario Campana, Eduardo Magalhães Rego
Journal: Blood Advances
Blood Adv (2017) 1 (Suppl): 80–83.
https://doi.org/10.1182/bloodadvances.2017GS102444
Published: 2017